Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Cannasouth
Cannasouth
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Cannasouth
Stock Price
$0.1
2024-07-15
Market Capitalization
$32.4 M
2024-07-15
Revenue
$955 K
FY, 2023
Cannasouth Summary
Company Summary
Overview
Cannasouth is a biopharmaceutical company engaged in the research, development, and cultivation of medical cannabis. It manufactures medicinal cannabinoid products.
Type
Public
Status
Active
Founded
2017
Website
https://www.cannasouth.co.nz/
Cybersecurity rating
Sectors
Healthcare
cannabis
drug development
pharma
Homepage
Linkedin
instagram
facebook
youtube
twitter
Table of Contents
Financials
Competitors
Cannasouth Financials
Summary Financials
Revenue (FY, 2023)
$955.0K
Gross profit (FY, 2023)
($1.2M)
Net income (FY, 2023)
($8.8M)
Cash (FY, 2023)
$2.3M
EBIT (FY, 2023)
($8.7M)
Enterprise value
$33.0M
Competitors and Similar Companies
CC-Pharma
Healthcare - Private
MTL Cannabis
Healthcare - Public
GB Sciences
Healthcare - Public
Barak Investment House
Financial Services - Public
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top